Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000160355 | SCV000210861 | benign | not specified | 2014-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000232767 | SCV000291002 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410320 | SCV000489925 | likely benign | Fanconi anemia complementation group J | 2016-08-09 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411863 | SCV000489926 | likely benign | Ovarian neoplasm | 2016-08-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000579952 | SCV000684183 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990004 | SCV001140766 | likely benign | Familial cancer of breast | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000990004 | SCV001934461 | likely benign | Familial cancer of breast | 2021-02-26 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000990004 | SCV004019364 | likely benign | Familial cancer of breast | 2023-02-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV004544468 | SCV004763371 | likely benign | BRIP1-related disorder | 2019-02-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |